Caisse de Depot et Placement du Quebec (CDPQ)’s Horizon Therapeutics Public Limited Company Ordinary Shares HZNP Stock Holding History

Caisse de Depot et Placement du Quebec (CDPQ)’s Portfolio HZNP Stock Details HZNP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-81,375	Closed	-$8.88M	–	567
2023 Q1	$8.88M	Buy	81,375 +4,598	+6%	+$508K	0.03%	350
2022 Q4	$8.74M	Sell	76,777 -885,406	-92%	-$73.5M	0.03%	339
2022 Q3	$59.5M	Buy	962,183 +919,779	+2,169%	+$64.3M	0.17%	124
2022 Q2	$3.38M	Sell	42,404 -2,458	-5%	-$233K	0.01%	410
2022 Q1	$4.72M	Buy	44,862 +16,700	+59%	+$1.63M	0.01%	422
2021 Q4	$3.04M	Buy	28,162 +22,600	+406%	+$2.47M	0.01%	431
2021 Q3	$609K	Buy	5,562 +400	+8%	+$41.5K	﹤0.01%	491
2021 Q2	$483K	Buy	5,162 +2,230	+76%	+$205K	﹤0.01%	472
2021 Q1	$270K	Buy	+2,932	New	+$247K	﹤0.01%	658

Other funds holding HZNP

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

PCM

Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return

HBK Investments Dallas, Texas $9.85B AUM 55.6% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Caisse de Depot et Placement du Quebec (CDPQ)'s HZNP Position: Q2 2023 in Review

Caisse de Depot et Placement du Quebec (CDPQ) sold out of Horizon Therapeutics Public Limited Company Ordinary Shares (HZNP) in Q2 2023, closing a stake of 81,375 shares — an estimated $8.88M sold.

Caisse de Depot et Placement du Quebec (CDPQ) first reported a position in HZNP in Q1 2021 and held it in 9 quarters. The position peaked at $59.5M in Q3 2022. 519 funds tracked by Wall St. Rank hold HZNP as of Q2 2023.

Caisse de Depot et Placement du Quebec (CDPQ) reported no remaining Horizon Therapeutics Public Limited Company Ordinary Shares position as of Q2 2023 after selling out during the quarter.
Caisse de Depot et Placement du Quebec (CDPQ) sold 81,375 Horizon Therapeutics Public Limited Company Ordinary Shares shares in Q2 2023, an estimated $8.88M.
Caisse de Depot et Placement du Quebec (CDPQ) first reported a position in Horizon Therapeutics Public Limited Company Ordinary Shares in Q1 2021 and held it in 9 quarters.
Caisse de Depot et Placement du Quebec (CDPQ)'s Horizon Therapeutics Public Limited Company Ordinary Shares position peaked at $59.5M in Q3 2022.
519 funds tracked by Wall St. Rank held Horizon Therapeutics Public Limited Company Ordinary Shares as of Q2 2023.

Based on Caisse de Depot et Placement du Quebec (CDPQ)'s 13F filing for Q2 2023, filed 14 Aug 2023.